Transparency: cbdMD seems to be going through a transition with their third-party testing practices. Until recently, they only released a lab report for the CBD concentrate they use for all their products, but would not show potency testing for individual products. That seems to be changing. Currently, the only lab report on the website is for their concentrate (and it’s over a year old). But if you contact customer service, they’ll send you a lab report for any product.
Cannabidiol (CBD) has NOT been proven to treat, relieve, nor cure any disease or medical condition listed on this site. The medical studies, controlled tests, and health information offered on Cannabidiol Life of allcbdoilbenefits.com (or any variation of the URL) is an expressed summarization of our personal conducted research done by me and few friends in the business. The information provided on this site is designed to support, NEVER replace, the relationship that exists between a patient/site visitor and the patient’s/site visitor’s physician.
It’s fair to say that the CBD market is thriving. According to market intelligence company Hemp Business Journal, $130 million worth of products containing the cannabinoid were bought in the U.S. in 2016. And that figure is only set to rise in the years to come, the data analyst believes. Indeed, the source estimates that consumer sales of CBD goods will total an astounding $2.1 billion by 2020 – buoyed, perhaps, by claims that the usage of such products can help alleviate the symptoms of chronic pain, depression and diabetes, to name but a few conditions.
We will be processing upwards of 60 tons of hemp this harvest for CBD without the use of “harsh chemicals”. The process is the same for hemp as it is for any other variety of cannabis. Please stop misleading your readers. Furthermore, we are happy to provide a CoA for every product we manufacture. Consumers can trust a lot of US companies, including ours – the days of importing nasty paste from China are long behind the industry. Joshua Camp; CEO LabCanna LLC
Because our hemp oil products are categorized as dietary supplements in the United States, we comply with the FDA’s DSHEA guidelines and cannot endorse any specific medical benefits of CBD or our CBD oil. To further comply with FDA regulations, HempMeds® does not list a Recommended Daily Intake (RDI) of our own, nor do we provide a Daily Value (%DV) for any of our products. We encourage you to browse the thousands of reputable studies regarding CBD published online and talk with your doctor to see if a CBD oil supplement is right for you.
The passing of SB 218 through the Kentucky legislature created a new subsection of KRS 260.850m to 260.289, in which the Industrial Hemp Advisory Board outlines the purpose of an industrial hemp research program, establish license provisions, and create new requirements and license application procedures. This state’s approach is for the potential medical and industrial applications.